A 26-week result and a 48-week result are not the same measurement
One doctor recently coined the term Ozempic face to describe the deflation and sagging that often occurs to a users visage after they begin taking the drug
The influence of CKD severity was also addressed
After a flurry of questions about which dermatologist or plastic surgeon she had visited, she said, beaming, Im microdosing! Shamoon has joined the wave of people who are taking limited amounts not of psychedelics to which the microdosing trend usually applies but of the diabetes drug Ozempic (semaglutide), and other GLP-1 receptor agonists like Mounjaro
Tirzepatide is a novel glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for the treatment of type 2 diabetes mellitus and, more recently, for chronic weight management in adults with obesity or overweight with weight-related comorbidities, as per the MHRA Summary of Product Characteristics
Factors such as the desired degree of weight loss, glycemic control goals, and cost considerations play a role in determining the most suitable treatment